Table of Content

1 Ophthalmology Biologics Market Introduction and Overview
1.1 Ophthalmology Biologics Definition
1.2 Research Purposes
1.3 Report Timeline
1.4 Economic Analysis of Global Regions
1.5 Ophthalmology Biologics Industry Dynamic Analysis
1.5.1 Ophthalmology Biologics Market Trends Analysis
1.5.2 Ophthalmology Biologics Market Drivers Analysis
1.5.3 Ophthalmology Biologics Market Challenges Analysis
1.5.4 Ophthalmology Biologics Market Restraints Analysis
1.6 Inflation Analysis
1.7 The Impact of the Russian-Ukrainian War on the Market
1.8 Coronavirus Disease 2020 (COVID-19) Impact on Global
2 Global Ophthalmology Biologics Market Insights by Type
2.1 Market Size Insights by Types
2.2 Global Ophthalmology Biologics Revenue and Share by Type
3 Global Ophthalmology Biologics Market Insights by Application
3.1 Market Size Insights by Application
3.2 Global Ophthalmology Biologics Revenue and Share by Application (2019-2024)
4 Global Market Growth Insights
4.1 Global Ophthalmology Biologics Market Size (2019-2024)
4.2 Ophthalmology Biologics Growth Insights by Regions
4.2.1 Ophthalmology Biologics Market Size by Regions: 2019 VS 2024 VS 2030
4.2.2 Ophthalmology Biologics Revenue Market Size by Regions (2019-2024)
4.2.3 North America Ophthalmology Biologics Market Size (2019-2024)
4.2.4 Europe Ophthalmology Biologics Market Size (2019-2024)
4.2.5 Asia-Pacific Ophthalmology Biologics Market Size (2019-2024)
4.2.6 Latin America Ophthalmology Biologics Market Size (2019-2024)
4.2.7 Middle East & Africa Ophthalmology Biologics Market Size (2019-2024)
5 North America
5.1 North America Ophthalmology Biologics Revenue by Countries
5.1.1 North America Ophthalmology Biologics Revenue by Countries (2019-2024)
5.2 North America PEST Analysis
5.3 United States
5.4 Canada
6 Asia Pacific
6.1 Asia Pacific Ophthalmology Biologics Revenue by Countries
6.1.1 Asia Pacific Ophthalmology Biologics Revenue by Countries (2019-2024)
6.2 Asia-Pacific PEST Analysis
6.3 China
6.4 Japan
6.5 Korea
6.6 Southeast Asia
6.7 India
6.8 Australia
7 Europe
7.1 Europe Ophthalmology Biologics Revenue by Countries
7.1.1 Europe Ophthalmology Biologics Revenue by Countries (2019-2024)
7.2 Europe PEST Analysis
7.3 Germany
7.4 France
7.5 UK
7.6 Italy
7.7 Russia
7.8 Spain
7.9 Nordic
8 Latin America
8.1 Latin America Ophthalmology Biologics Revenue by Countries
8.1.1 Latin America Ophthalmology Biologics Revenue by Countries (2019-2024)
8.2 Latin America PEST Analysis
8.3 Brazil
8.4 Argentina
8.5 Mexico
9 Middle East & Africa
9.1 Middle East & Africa Ophthalmology Biologics Revenue by Countries
9.1.1 Middle East & Africa Ophthalmology Biologics Revenue by Countries (2019-2024)
9.2 Middle East & Africa PEST Analysis
9.3 Egypt
9.4 South Africa
9.5 UAE
9.6 Turkey
9.7 Saudi Arabia
10 Global Ophthalmology Biologics Market Competition, by Players
10.1 Global Ophthalmology Biologics Revenue and Market Share by Players
10.2 Market Concentration Rate
10.2.1 Top 3 Ophthalmology Biologics Players Market Share in 2023
10.2.2 Top 6 Ophthalmology Biologics Players Market Share in 2023
10.2.3 Market Competition Trend
10.3 Ophthalmology Biologics Players Head Office, Business Provided
10.4 Ophthalmology Biologics Mergers & Acquisitions
10.5 Ophthalmology Biologics New Entrants and Expansion Plans
11 Players Profiles
11.1 Allergan
11.1.1 Allergan Company Profile
11.1.2 Ophthalmology Biologics Product Overview
11.1.3 Allergan Ophthalmology Biologics Market Performance (2019-2024)
11.1.4 Allergan Business Overview
11.1.5 Recent Developments and Plans
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Company Profile
11.2.2 Ophthalmology Biologics Product Overview
11.2.3 Bristol-Myers Squibb Ophthalmology Biologics Market Performance (2019-2024)
11.2.4 Bristol-Myers Squibb Business Overview
11.2.5 Recent Developments and Plans
11.3 Genzyme Corporation
11.3.1 Genzyme Corporation Company Profile
11.3.2 Ophthalmology Biologics Product Overview
11.3.3 Genzyme Corporation Ophthalmology Biologics Market Performance (2019-2024)
11.3.4 Genzyme Corporation Business Overview
11.3.5 Recent Developments and Plans
11.4 Ocular Therapeutix
11.4.1 Ocular Therapeutix Company Profile
11.4.2 Ophthalmology Biologics Product Overview
11.4.3 Ocular Therapeutix Ophthalmology Biologics Market Performance (2019-2024)
11.4.4 Ocular Therapeutix Business Overview
11.4.5 Recent Developments and Plans
11.5 UCBCares
11.5.1 UCBCares Company Profile
11.5.2 Ophthalmology Biologics Product Overview
11.5.3 UCBCares Ophthalmology Biologics Market Performance (2019-2024)
11.5.4 UCBCares Business Overview
11.5.5 Recent Developments and Plans
11.6 Alimera Sciences
11.6.1 Alimera Sciences Company Profile
11.6.2 Ophthalmology Biologics Product Overview
11.6.3 Alimera Sciences Ophthalmology Biologics Market Performance (2019-2024)
11.6.4 Alimera Sciences Business Overview
11.6.5 Recent Developments and Plans
11.7 Swedish Orphan Biovitrum
11.7.1 Swedish Orphan Biovitrum Company Profile
11.7.2 Ophthalmology Biologics Product Overview
11.7.3 Swedish Orphan Biovitrum Ophthalmology Biologics Market Performance (2019-2024)
11.7.4 Swedish Orphan Biovitrum Business Overview
11.7.5 Recent Developments and Plans
11.8 Genentech
11.8.1 Genentech Company Profile
11.8.2 Ophthalmology Biologics Product Overview
11.8.3 Genentech Ophthalmology Biologics Market Performance (2019-2024)
11.8.4 Genentech Business Overview
11.8.5 Recent Developments and Plans
11.9 F. Hoffmann-La Roche
11.9.1 F. Hoffmann-La Roche Company Profile
11.9.2 Ophthalmology Biologics Product Overview
11.9.3 F. Hoffmann-La Roche Ophthalmology Biologics Market Performance (2019-2024)
11.9.4 F. Hoffmann-La Roche Business Overview
11.9.5 Recent Developments and Plans
11.10 AbbVie
11.10.1 AbbVie Company Profile
11.10.2 Ophthalmology Biologics Product Overview
11.10.3 AbbVie Ophthalmology Biologics Market Performance (2019-2024)
11.10.4 AbbVie Business Overview
11.10.5 Recent Developments and Plans
11.11 Janssen Biotech
11.11.1 Janssen Biotech Company Profile
11.11.2 Ophthalmology Biologics Product Overview
11.11.3 Janssen Biotech Ophthalmology Biologics Market Performance (2019-2024)
11.11.4 Janssen Biotech Business Overview
11.11.5 Recent Developments and Plans
11.12 Bausch & Lomb
11.12.1 Bausch & Lomb Company Profile
11.12.2 Ophthalmology Biologics Product Overview
11.12.3 Bausch & Lomb Ophthalmology Biologics Market Performance (2019-2024)
11.12.4 Bausch & Lomb Business Overview
11.12.5 Recent Developments and Plans
12 Global Ophthalmology Biologics Forecast Market Insights by Type
12.1 Global Ophthalmology Biologics Revenue Market Forecast by Type (2024-2030)
13 Global Ophthalmology Biologics Forecast Market Insights by Application
13.1 Ophthalmology Biologics Revenue Market Forecast by Application (2024-2030)
14 Global Market Growth Forecast Insights
14.1 Global Ophthalmology Biologics Forecast Market Size (2024-2030)
14.2 Ophthalmology Biologics Growth Forecast Insights by Regions
14.2.1 Ophthalmology Biologics Revenue Forecast Market Size by Regions (2024-2030)
14.2.2 North America Ophthalmology Biologics Forecast Market Size (2024-2030)
14.2.3 Europe Ophthalmology Biologics Forecast Market Size (2024-2030)
14.2.4 Asia-Pacific Ophthalmology Biologics Forecast Market Size (2024-2030)
14.2.5 Latin America Ophthalmology Biologics Forecast Market Size (2024-2030)
14.2.6 Middle East & Africa Ophthalmology Biologics Forecast Market Size (2024-2030)
15 Methodology and Data Source
15.1 A Methodology
15.1.1 Research Process
15.1.2 Market Size Estimation
15.1.3 Market Breakdown and Data Triangulation
15.2 B Data Source
15.2.1 Legal Disclaimer